Page last updated: 2024-10-25

clomipramine and Disease Models, Animal

clomipramine has been researched along with Disease Models, Animal in 96 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" After oral treatment with clomipramine (50 mg/kg/day) for four weeks, most of the depression-like behaviors were reversed, whereas the motivational reduction was not clearly affected."7.88Differential effects of clomipramine on depression-like behaviors induced by the chronic social defeat paradigm in tree shrews. ( Duan, Y; Li, M; Li, Y; Liang, J; Meng, X; Qi, K; Shen, F; Sui, N, 2018)
"Quinpirole (QNP) sensitization is one of the commonly used animal models of obsessive-compulsive disorder (OCD)."7.85Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole. ( Hatalova, H; Pistikova, A; Radostova, D; Stuchlik, A; Vales, K, 2017)
"This study examined the integrity of hypothalamic-pituitary-adrenal (HPA) axis in clomipramine model of depression."7.70Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. ( Karanth, KS; Kumar, KB; Prathiba, J, 1998)
"Day-night differences in locomotor and anxiety-related behavior and brain serotonin metabolism were examined in adult Syrian hamsters that received clomipramine (15 mg/kg) or vehicle from day 8 to day 21 of life."7.70Effects of neonatal clomipramine treatment on locomotor activity, anxiety-related behavior and serotonin turnover in Syrian hamsters. ( Cardinali, DP; Gregoretti, L; Kargieman, L; Yannielli, PC, 1999)
"Chagas disease is an important public health problem in Latin America, and its treatment by chemotherapy with benznidazole (BZ) or nifurtimox remains unsatisfactory."5.43Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. ( Aoki, MP; García, MC; Jimenez-Kairuz, AF; Manzo, RH; Ponce, NE; Sanmarco, LM, 2016)
"In teeth with ligature, mean alveolar bone loss varied from 0."5.35Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats. ( Gaio, EJ; Rosing, CK; Soletti, AC, 2009)
"The present study was to investigate the effect of electroacupuncture (EA) combined with chlorimipramine on the sucrose preference of depressive rats induced by chronic mild stress (CMS)."5.33Sucrose preference is restored by electro-acupuncture combined with chlorimipramine in the depression-model rats. ( Cao, XD; Li, XY; Wu, GC; Yu, J, 2006)
"Depression is associated with deficiencies in monoaminergic transmitters and possibly neurotrophins."5.32Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. ( Fang, J; Feng, P; Guan, Z; Yang, X, 2003)
" After oral treatment with clomipramine (50 mg/kg/day) for four weeks, most of the depression-like behaviors were reversed, whereas the motivational reduction was not clearly affected."3.88Differential effects of clomipramine on depression-like behaviors induced by the chronic social defeat paradigm in tree shrews. ( Duan, Y; Li, M; Li, Y; Liang, J; Meng, X; Qi, K; Shen, F; Sui, N, 2018)
"Quinpirole (QNP) sensitization is one of the commonly used animal models of obsessive-compulsive disorder (OCD)."3.85Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole. ( Hatalova, H; Pistikova, A; Radostova, D; Stuchlik, A; Vales, K, 2017)
" In this study, taking advantage of the transparency of larval zebrafish, Danio rerio, we assessed cardiovascular toxicity of seven known human cardiotoxic drugs (aspirin, clomipramine hydrochloride, cyclophosphamide, nimodipine, quinidine, terfenadine and verapamil hydrochloride) and two non-cardiovascular toxicity drugs (gentamicin sulphate and tetracycline hydrochloride) in zebrafish using six specific phenotypic endpoints: heart rate, heart rhythm, pericardial edema, circulation, hemorrhage and thrombosis."3.80Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish. ( Dong, QX; Gao, JM; He, JH; Huang, CJ; Li, CQ; Xu, YQ; Xuan, YX; Yu, HP; Zhu, JJ, 2014)
" During and at the end point of the chronic stress experiment, food consumption, body weight, adrenal gland, thymus and spleen indices, behavior scores, sucrose consumption, and stress hormone levels were measured."3.78Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression. ( Chen, T; Jia, W; Jia, Z; Jiang, T; Lin, J; Qiu, Y; Su, M; Wang, X; Xie, X; Zeng, C; Zhao, A; Zhao, T; Zhou, M, 2012)
"To develop a behavioral model in mice that is capable of mimicking some distinctive symptoms of human posttraumatic trigeminal neuropathic pain such as spontaneous pain, cold allodynia, and chemical÷inflammatory hyperalgesia, and to use this model to investigate the antinociceptive effects of clomipramine and tramadol, two drugs used for the treatment of neuropathic pain."3.77Antihyperalgesic effects of clomipramine and tramadol in a model of posttraumatic trigeminal neuropathic pain in mice. ( Alvarez, P; Brun, A; Constandil, L; Correa, A; Hernández, A; Labertrandie, A; Lopez, J; Pelissier, T, 2011)
" The authors set out to document plasma and peritoneal diasylate clomipramine concentration after resuscitation with lipid emulsion in a rabbit model of clomipramine-induced hypotension."3.75Correlation of plasma and peritoneal diasylate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits. ( Cave, G; Harvey, M; Hoggett, K, 2009)
"The present study was designed to evaluate the antidepressant effect of electroacupuncture (EA) and the potential additive or synergistic effects of EA and clomipramine (CLO, a tricyclic antidepressant) in the mouse forced swimming test (FST) and chronic mild stress (CMS) induced depression-model rats."3.74Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents. ( Cao, XD; Li, XY; Liu, Q; Wang, J; Wang, YQ; Wu, GC; Yu, J, 2007)
" To examine these novel concepts of the pathophysiology of depression and antidepressant medication we have carried out a series of experiments using the chronic psychosocial stress paradigm in male tree shrews, an animal model with a high validity for the pathophysiology of depressive disorders, in which the animals were treated with the tricyclic antidepressant compound clomipramine."3.72Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. ( Czéh, B; Flügge, G; Fuchs, E, 2004)
" The non-selective noradrenaline (NA) and serotonin (5-HT) reuptake inhibitors imipramine, amitriptyline and clomipramine displayed anti-inflammatory activity in the carrageenan model of paw inflammation."3.72Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat. ( Abdel-Salam, OM; El-Shenawy, SM; Nofal, SM, 2003)
"Olfactory bulbectomy, neonatal clomipramine administration, and maternal deprivation have been employed as animal models of depression."3.71Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. ( Norrholm, SD; Ouimet, CC, 2001)
"Clomipramine (CLI), a REM sleep suppressant, alleviates symptoms of depression in adults but produces depressive behaviors if applied neonatally."3.71Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors. ( Feng, P; Ma, Y, 2002)
"This study examined the integrity of hypothalamic-pituitary-adrenal (HPA) axis in clomipramine model of depression."3.70Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. ( Karanth, KS; Kumar, KB; Prathiba, J, 1998)
"Neonatal treatment with clomipramine induces behavioral alterations during adulthood that resemble symptoms observed in human depression."3.70Pharmacological features of masculine sexual behavior in an animal model of depression. ( Bonilla-Jaime, H; Retana-Marquez, S; Velazquez-Moctezuma, J, 1998)
"Day-night differences in locomotor and anxiety-related behavior and brain serotonin metabolism were examined in adult Syrian hamsters that received clomipramine (15 mg/kg) or vehicle from day 8 to day 21 of life."3.70Effects of neonatal clomipramine treatment on locomotor activity, anxiety-related behavior and serotonin turnover in Syrian hamsters. ( Cardinali, DP; Gregoretti, L; Kargieman, L; Yannielli, PC, 1999)
"The effects of substituted benzamides, sulpiride and raclopride on experimental models of depression were studied in male rats after acute or chronic administration in comparison to those of the classical antidepressant, clomipramine."3.70Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats. ( Arezzi, A; Drago, F; Virzì, A, 2000)
"Canine acral lick dermatitis is a naturally occurring disorder in which excessive licking of paws or flank can produce ulcers and infection that require medical treatment."2.67Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. ( Kriete, M; Rapoport, JL; Ryland, DH, 1992)
"Narcolepsy is an emblematic, unique disease within sleep disorders that is characterised by excessive daytime sleepiness, cataplexy and other abnormal manifestations of REM sleep."2.48[Diagnostic and therapeutic update in narcolepsy]. ( Santamaria-Cano, J, 2012)
"In addition, depression is characterized by a decreased functioning of the serotonergic system due to changes in the activity or expression of its receptors including, most significantly, 5-HT1A, 5-HT2A, and 5-HT3 in brain regions that regulate mood, emotions, and memory, such as the prefrontal cortex, hippocampus, and amygdala."1.91Alterations of learning and memory are accompanied by alterations in the expression of 5-HT receptors, glucocorticoid receptor and brain-derived neurotrophic factor in different brain regions of an animal model of depression generated by neonatally male t ( Arteaga-Silva, M; Bonilla-Jaime, H; Cerbón, M; Limón-Morales, O; Molina-Jiménez, T; Morales-Quintero, K, 2023)
"Depression is a common mental disease affecting a lot of people of all ages around the world."1.51Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats. ( Abdelmelek, H; Ammari, M; Lassoued, A; Othman, H; Sakly, M, 2019)
"Chagas disease is an important public health problem in Latin America, and its treatment by chemotherapy with benznidazole (BZ) or nifurtimox remains unsatisfactory."1.43Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. ( Aoki, MP; García, MC; Jimenez-Kairuz, AF; Manzo, RH; Ponce, NE; Sanmarco, LM, 2016)
"Depression is associated with structural and neurochemical changes in limbic structures, including the hippocampus, that control emotion and mood."1.39Phospholipase D-mTOR signaling is compromised in a rat model of depression. ( Feng, P; Huang, C, 2013)
" Results of this study provide useful information for dosage adjustment of clomipramine in hyperlipidaemia."1.37Pharmacokinetics of clomipramine, an antidepressant, in poloxamer 407-induced hyperlipidaemic model rats. ( Fukushima, K; Ito, Y; Kobuchi, S; Shibata, M; Sugioka, N; Takada, K, 2011)
"Abolition of mechanical hyperalgesia was observed in mononeuropathic rats after five injections of clomipramine (5 mg·kg(-1) , s."1.37Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? ( Courteix, C; Eschalier, A; Fialip, J; Libert, F; Loiodice, S; Privat, AM; Wattiez, AS, 2011)
"Clomipramine was inactive alone and did not alter the effects of mu agonists."1.36Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy. ( Banks, ML; Negus, SS; Rice, KC, 2010)
"In teeth with ligature, mean alveolar bone loss varied from 0."1.35Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats. ( Gaio, EJ; Rosing, CK; Soletti, AC, 2009)
"The present study was to investigate the effect of electroacupuncture (EA) combined with chlorimipramine on the sucrose preference of depressive rats induced by chronic mild stress (CMS)."1.33Sucrose preference is restored by electro-acupuncture combined with chlorimipramine in the depression-model rats. ( Cao, XD; Li, XY; Wu, GC; Yu, J, 2006)
"Depression is associated with deficiencies in monoaminergic transmitters and possibly neurotrophins."1.32Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. ( Fang, J; Feng, P; Guan, Z; Yang, X, 2003)
"Because human endogenous depression is associated with abnormal REM sleep and an elevated nocturnal Tb, these results give further support for the validity of the CLI model of depression and provide insight into the relationships among Tb, Ta, REM sleep and depression."1.29The effects of a 3-day increase of ambient temperature on body temperature and REM sleep in an animal model of depression. ( Rosenthal, MS; Vogel, GW, 1994)
"One theory about the pathogenesis of endogenous depression is that decreased serotonergic (5-HT) neurotransmission is involved in producing the disorder."1.29Decreased raphe unit activity in a rat model of endogenous depression. ( Neill, DB; Vogel, GW; Yavari, P, 1993)
" Moreover, long term administration of both imipramine or SKF 38393 down regulated D1 dopamine receptor number in the prefrontal cortex, while the association of the two drugs resulted in a receptor density similar to that of control rats."1.29Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine. ( Gambarana, C; Ghiglieri, O; Graziella de Montis, M, 1995)
" Chronic administration of the selective serotonin re-uptake inhibitors fluoxetine and clomipramine (CMI) at 5 mg/kg per day and fluvoxamine at 10 mg/kg twice a day significantly decreased schedule-induced polydipsia (SIP) on day 15 and throughout the remainder of the study compared to control rats."1.29Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. ( Corbett, R; Cornfeldt, M; Dunn, RW; Smith, C; Szewczak, M; Woods, A, 1993)
"This suggests that an animal model of endogenous depression should show diminished sexual activity."1.28Diminished sexual activity in a new animal model of endogenous depression. ( Hagler, M; Hennessey, A; Kors, D; Neill, D; Vogel, G, 1990)
"Fengabine (SL 79."1.27Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile. ( Bartholini, G; Depoortere, H; Lloyd, KG; Sanger, D; Zivkovic, B, 1987)

Research

Studies (96)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.08)18.7374
1990's19 (19.79)18.2507
2000's32 (33.33)29.6817
2010's37 (38.54)24.3611
2020's6 (6.25)2.80

Authors

AuthorsStudies
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W2
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Zhang, S1
Hu, J1
Liu, G1
Wu, H1
Li, M2
Shi, C1
Liu, Q3
Faucher, P1
Dries, A1
Mousset, PY1
Leboyer, M1
Dore, J1
Beracochea, D1
Abdelmeguid, NE1
Hammad, TM1
Abdel-Moneim, AM1
Salam, SA1
Limón-Morales, O1
Morales-Quintero, K1
Arteaga-Silva, M1
Molina-Jiménez, T1
Cerbón, M1
Bonilla-Jaime, H3
Chakraborty, S1
Tripathi, SJ1
Raju, TR2
Shankaranarayana Rao, BS1
Shen, F1
Qi, K1
Duan, Y1
Li, Y1
Liang, J1
Meng, X1
Sui, N1
Cavaliere, F1
Fornarelli, A1
Bertan, F1
Russo, R1
Marsal-Cots, A1
Morrone, LA1
Adornetto, A1
Corasaniti, MT1
Bano, D1
Bagetta, G1
Nicotera, P1
Othman, H1
Ammari, M1
Lassoued, A1
Sakly, M1
Abdelmelek, H1
Feng, P4
Huang, C1
Strauss, M1
Lo Presti, MS2
Bazán, PC1
Baez, A2
Fauro, R1
Esteves, B1
Sanchez Negrete, O1
Cremonezzi, D1
Paglini-Oliva, PA2
Rivarola, HW2
Saito, K1
Maekawa, K1
Ishikawa, M1
Senoo, Y1
Urata, M1
Murayama, M1
Nakatsu, N1
Yamada, H1
Saito, Y1
Qin, D1
Chu, X1
Feng, X1
Li, Z1
Yang, S1
Lü, L1
Yang, Q1
Pan, L1
Yin, Y1
Li, J1
Xu, L1
Chen, L1
Hu, X1
García, MC1
Ponce, NE1
Sanmarco, LM1
Manzo, RH1
Jimenez-Kairuz, AF1
Aoki, MP1
Hatalova, H1
Radostova, D1
Pistikova, A1
Vales, K1
Stuchlik, A1
Duque, A1
Vinader-Caerols, C1
Monleón, S1
Mao, Q1
Huang, Z1
Ip, S1
Che, C1
Matrisciano, F2
Caruso, A1
Orlando, R1
Marchiafava, M1
Bruno, V1
Battaglia, G1
Gruber, SH1
Melchiorri, D1
Tatarelli, R1
Girardi, P1
Mathè, AA1
Nicoletti, F2
Amato, D1
Stasi, MA1
Borsini, F1
Nencini, P2
Kokras, N1
Antoniou, K1
Dalla, C2
Bekris, S1
Xagoraris, M1
Ovestreet, DH1
Papadopoulou-Daifoti, Z3
Harvey, M1
Cave, G1
Hoggett, K1
Soletti, AC1
Gaio, EJ1
Rosing, CK1
Li, B1
Zhu, HY1
Wang, YQ2
Yu, J3
Wu, GC3
Pitychoutis, PM2
Griva, E1
Ioannou, K1
Tsitsilonis, OE1
Hobara, T1
Uchida, S1
Otsuki, K1
Matsubara, T1
Funato, H1
Matsuo, K1
Suetsugi, M1
Watanabe, Y1
Modafferi, AM1
Togna, GI1
Barone, Y1
Pinna, G1
Scaccianoce, S1
Lagus, M2
Gass, N2
Saharinen, J2
Saarela, J1
Porkka-Heiskanen, T3
Paunio, T2
Piras, G1
Giorgi, O1
Corda, MG1
Andersen, SL1
Greene-Colozzi, EA1
Sonntag, KC1
Banks, ML1
Rice, KC1
Negus, SS1
Gobbi, P1
Fernández, AR1
Enders, JE1
Fretes, R1
Gea, S1
Bhagya, V1
Srikumar, BN1
Rao, BS1
Rogel-Salazar, G1
López-Rubalcava, C1
Greene-Schloesser, DM1
Van der Zee, EA1
Sheppard, DK1
Castillo, MR1
Gregg, KA1
Burrow, T1
Foltz, H1
Slater, M1
Bult-Ito, A1
Wattiez, AS1
Libert, F1
Privat, AM1
Loiodice, S1
Fialip, J2
Eschalier, A2
Courteix, C2
Kobuchi, S1
Fukushima, K1
Shibata, M1
Ito, Y1
Sugioka, N1
Takada, K1
De Carolis, L1
Schepisi, C1
Milella, MS1
Shanahan, NA1
Velez, LP1
Masten, VL1
Dulawa, SC1
McDowell, AL1
Strohl, KP1
Alvarez, P1
Brun, A1
Labertrandie, A1
Lopez, J1
Correa, A1
Constandil, L1
Hernández, A1
Pelissier, T1
Sideris, AC1
Tsonis, PA1
Savelyev, SA1
Rantamäki, T1
Rytkönen, KM1
Castren, E1
Santamaria-Cano, J1
Savelyev, S1
Komorowski, M1
Huston, JP1
Klingenhegel, I1
Paulat, J1
Sackers, J1
Topic, B1
Kovács, Z1
Czurkó, A1
Kékesi, KA1
Juhász, G1
Wang, X1
Zeng, C1
Lin, J1
Chen, T1
Zhao, T1
Jia, Z1
Xie, X1
Qiu, Y1
Su, M1
Jiang, T1
Zhou, M1
Zhao, A1
Jia, W1
Zhu, JJ1
Xu, YQ1
He, JH1
Yu, HP1
Huang, CJ1
Gao, JM1
Dong, QX1
Xuan, YX1
Li, CQ1
Kreiss, DS1
Coffman, CF1
Fiacco, NR1
Granger, JC1
Helton, BM1
Jackson, JC1
Kim, LV1
Mistry, RS1
Mizer, TM1
Palmer, LV1
Vacca, JA1
Winkler, SS1
Zimmer, BA1
Sesia, T1
Bizup, B1
Grace, AA1
van Kampen, M1
Kramer, M1
Hiemke, C1
Flügge, G2
Fuchs, E3
Mavanji, V1
Datta, S1
van der Hart, MG1
Czéh, B2
de Biurrun, G1
Michaelis, T1
Watanabe, T1
Natt, O1
Frahm, J1
Ventura, R1
Cabib, S1
Puglisi-Allegra, S1
Willie, JT1
Chemelli, RM1
Sinton, CM1
Tokita, S1
Williams, SC1
Kisanuki, YY1
Marcus, JN1
Lee, C1
Elmquist, JK1
Kohlmeier, KA1
Leonard, CS1
Richardson, JA1
Hammer, RE1
Yanagisawa, M1
Abdel-Salam, OM1
Nofal, SM1
El-Shenawy, SM1
Retana-Marquez, S2
Vazquez-Palacios, G1
Velázquez-Moctezuma, J3
Guan, Z1
Yang, X1
Fang, J1
Fujii, S1
Asakura, M1
Kanai, S1
Tanaka, D1
Hishinumai, T1
Nagashima, H1
Cordner, AP1
Herwood, MB1
Helmreich, DL1
Parfitt, DB1
Consoli, D2
Fedotova, J1
Micale, V4
Sapronov, NS1
Drago, F5
Lino-de-Oliveira, C1
de Oliveira, RM1
Pádua Carobrez, A1
de Lima, TC1
del Bel, EA1
Guimarães, FS1
Wang, J1
Li, XY2
Cao, XD2
Leggio, GM1
Mazzola, C2
Yang, LM1
Hu, B1
Xia, YH1
Zhang, BL1
Zhao, H1
Scapagnini, G1
Colombrita, C1
Alkon, DL1
Maudhuit, C1
Hamon, M1
Adrien, J1
Woods, A1
Smith, C1
Szewczak, M1
Dunn, RW1
Cornfeldt, M1
Corbett, R1
Rosenthal, MS1
Vogel, GW2
Yavari, P1
Neill, DB1
Gambarana, C1
Ghiglieri, O1
Graziella de Montis, M1
Marvan, ML1
Chavez-Chavez, L1
Santana, S1
Martínez-Gomis, J1
Planas, ME1
Planelles, X1
Bartrons, R1
Sánchez, S1
Szechtman, H1
Sulis, W1
Eilam, D1
Prathiba, J1
Kumar, KB1
Karanth, KS1
Vijayakumar, M1
Meti, BL1
Yannielli, PC1
Kargieman, L1
Gregoretti, L1
Cardinali, DP1
Coudoré-Civiale, MA1
Boucher, M1
Méen, M1
Ardid, D1
Arezzi, A1
Virzì, A1
Nicolosi, A1
Lo Menzo, G1
Takamori, K1
Yoshida, S1
Okuyama, S1
Norrholm, SD1
Ouimet, CC1
Ma, Y1
Rapoport, JL2
Ryland, DH1
Kriete, M1
Diaz Ruiz, O1
Grindlinger, HM1
Ramsay, E1
Hartley, P2
Neill, D4
Hagler, M4
Kors, D4
Vogel, G4
Hennessey, A1
Lloyd, KG1
Zivkovic, B1
Sanger, D1
Depoortere, H1
Bartholini, G1

Reviews

1 review available for clomipramine and Disease Models, Animal

ArticleYear
[Diagnostic and therapeutic update in narcolepsy].
    Revista de neurologia, 2012, May-21, Volume: 54 Suppl 3

    Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Chil

2012

Trials

1 trial available for clomipramine and Disease Models, Animal

ArticleYear
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
    Archives of general psychiatry, 1992, Volume: 49, Issue:7

    Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Disease

1992

Other Studies

94 other studies available for clomipramine and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Chronic clomipramine treatment increases hippocampal volume in rats exposed to chronic unpredictable mild stress.
    Translational psychiatry, 2022, 06-10, Volume: 12, Issue:1

    Topics: Animals; Antidepressive Agents; Clomipramine; Depression; Disease Models, Animal; Hippocampus; Human

2022
Synergistic effects of
    Beneficial microbes, 2022, Aug-03, Volume: 13, Issue:3

    Topics: Animals; Clomipramine; Curcumin; Depression; Depressive Disorder; Disease Models, Animal; Glutamine;

2022
Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.
    Neurochemical research, 2022, Volume: 47, Issue:11

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antioxidants; Brain-Derived Neurot

2022
Alterations of learning and memory are accompanied by alterations in the expression of 5-HT receptors, glucocorticoid receptor and brain-derived neurotrophic factor in different brain regions of an animal model of depression generated by neonatally male t
    Behavioural brain research, 2023, 10-18, Volume: 455

    Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Clomipramine; Depression; Disease Models, Animal;

2023
Brain stimulation rewarding experience attenuates neonatal clomipramine-induced adulthood anxiety by reversal of pathological changes in the amygdala.
    Progress in neuro-psychopharmacology & biological psychiatry, 2020, 12-20, Volume: 103

    Topics: Amygdala; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Anxiety; Biogenic Monoamines;

2020
Differential effects of clomipramine on depression-like behaviors induced by the chronic social defeat paradigm in tree shrews.
    Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:10

    Topics: Anhedonia; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depression; Di

2018
The tricyclic antidepressant clomipramine inhibits neuronal autophagic flux.
    Scientific reports, 2019, 03-19, Volume: 9, Issue:1

    Topics: Affective Disorders, Psychotic; Animals; Antidepressive Agents, Tricyclic; Autophagy; Caenorhabditis

2019
Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats.
    Behavioural brain research, 2019, 11-18, Volume: 374

    Topics: Animals; Antidepressive Agents; Clomipramine; Depression; Depressive Disorder; Disease Models, Anima

2019
Phospholipase D-mTOR signaling is compromised in a rat model of depression.
    Journal of psychiatric research, 2013, Volume: 47, Issue:5

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Brain; Choline; Clomipramine; Depressio

2013
Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
    Parasitology international, 2013, Volume: 62, Issue:3

    Topics: Animals; Chagas Disease; Clomipramine; Disease Models, Animal; Drug Evaluation, Preclinical; Electro

2013
Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.
    Toxicological sciences : an official journal of the Society of Toxicology, 2014, Volume: 141, Issue:2

    Topics: Amitriptyline; Animals; Bile Ducts; Biomarkers; Chemical and Drug Induced Liver Injury; Chromatograp

2014
The first observation of seasonal affective disorder symptoms in Rhesus macaque.
    Behavioural brain research, 2015, Oct-01, Volume: 292

    Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Clomipramine; Depression; Disease Models, An

2015
Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Animals; Chagas Disease; Clomipramine; Disease Models, Animal; Drug Administration Schedule; Drug Co

2016
Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole.
    Behavioural brain research, 2017, 01-15, Volume: 317

    Topics: Analysis of Variance; Animals; Avoidance Learning; Clomipramine; Disease Models, Animal; Dopamine Ag

2017
Effects of social stress and clomipramine on emotional memory in mice.
    Acta neurobiologiae experimentalis, 2016, Volume: 76, Issue:3

    Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Avoidance Learning; Clomipramine; D

2016
Antidepressant-like effect of ethanol extract from Paeonia lactiflora in mice.
    Phytotherapy research : PTR, 2008, Volume: 22, Issue:11

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Blepharoptosis; Clomipramine; Depression; Dise

2008
Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.
    Neuropharmacology, 2008, Volume: 55, Issue:4

    Topics: Amino Acids; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Bridged Bicyclo Compounds,

2008
Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.
    Psychopharmacology, 2008, Volume: 200, Issue:2

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Clomipramine; Clozapine; Disea

2008
Sex-related differential response to clomipramine treatment in a rat model of depression.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:8

    Topics: Animals; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Disease Models, Animal; Female;

2009
Correlation of plasma and peritoneal diasylate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2009, Volume: 16, Issue:2

    Topics: Animals; Chromatography, High Pressure Liquid; Clomipramine; Dialysis Solutions; Disease Models, Ani

2009
Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats.
    Acta odontologica Scandinavica, 2009, Volume: 67, Issue:2

    Topics: Alveolar Bone Loss; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; C

2009
Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:11

    Topics: Animals; Clomipramine; Depression; Disease Models, Animal; Exploratory Behavior; Freezing Reaction,

2009
Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?
    The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:9

    Topics: Animals; Antidepressive Agents, Tricyclic; Cell Proliferation; Cells, Cultured; Chronic Disease; Clo

2009
Altered gene expression of histone deacetylases in mood disorder patients.
    Journal of psychiatric research, 2010, Volume: 44, Issue:5

    Topics: Animals; Antidepressive Agents; Clomipramine; Corticotropin-Releasing Hormone; Dexamethasone; Diseas

2010
Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.
    Neuropharmacology, 2010, Volume: 58, Issue:7

    Topics: Anabolic Agents; Androgens; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Brain; Brai

2010
Gene expression patterns in a rodent model for depression.
    The European journal of neuroscience, 2010, Volume: 31, Issue:8

    Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Female; Gene Expression; Male; O

2010
Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.
    Psychopharmacology, 2010, Volume: 211, Issue:4

    Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Clomipramine; Depression; Desi

2010
A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals.
    Biological psychiatry, 2010, Oct-15, Volume: 68, Issue:8

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Corpus

2010
Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Clomipramine; Disease Models, Animal; Dose-Response R

2010
Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi.
    Parasitology research, 2010, Volume: 107, Issue:5

    Topics: Allopurinol; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Chagas Disea

2010
Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.
    Psychopharmacology, 2011, Volume: 214, Issue:2

    Topics: Acetylcholinesterase; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents, Second

2011
Evaluation of the anxiolytic-like effects of clomipramine in two rat strains with different anxiety vulnerability (Wistar and Wistar-Kyoto rats): participation of 5-HT1A receptors.
    Behavioural pharmacology, 2011, Volume: 22, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Clo

2011
Predictive validity of a non-induced mouse model of compulsive-like behavior.
    Behavioural brain research, 2011, Aug-01, Volume: 221, Issue:1

    Topics: Animals; Anxiety; Behavior, Animal; Clomipramine; Compulsive Behavior; Desipramine; Disease Models,

2011
Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?
    British journal of pharmacology, 2011, Volume: 163, Issue:4

    Topics: Analgesics; Animals; Antidepressive Agents; Clomipramine; Cyclopropanes; Diabetes Mellitus, Experime

2011
Pharmacokinetics of clomipramine, an antidepressant, in poloxamer 407-induced hyperlipidaemic model rats.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:4

    Topics: Animals; Antidepressive Agents; Blood-Brain Barrier; Brain; Clomipramine; Disease Models, Animal; Ev

2011
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
    Psychopharmacology, 2011, Volume: 218, Issue:4

    Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compuls

2011
Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Biological psychiatry, 2011, Dec-01, Volume: 70, Issue:11

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Adrenergic beta-Antagonists; Adrenergi

2011
Sleep-related epilepsy in a Long-Evans hooded rat model of depression.
    Sleep & breathing = Schlaf & Atmung, 2012, Volume: 16, Issue:4

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dise

2012
Antihyperalgesic effects of clomipramine and tramadol in a model of posttraumatic trigeminal neuropathic pain in mice.
    Journal of orofacial pain, 2011,Fall, Volume: 25, Issue:4

    Topics: Acetone; Analgesics, Opioid; Animals; Capsaicin; Clomipramine; Disease Models, Animal; Formaldehyde;

2011
5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: sex differences exposed.
    Neuroscience, 2012, May-17, Volume: 210

    Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Clomipramine; Depression; Disease Models, Animal;

2012
Sleep homeostasis and depression: studies with the rat clomipramine model of depression.
    Neuroscience, 2012, Jun-14, Volume: 212

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depress

2012
Inter-tissue networks between the basal forebrain, hippocampus, and prefrontal cortex in a model for depression caused by disturbed sleep.
    Journal of neurogenetics, 2012, Volume: 26, Issue:3-4

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Disease Model

2012
Distance from source of reward as a marker for extinction-induced "despair": modulation by the antidepressants clomipramine and citalopram.
    Neuroscience, 2012, Oct-25, Volume: 223

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Clomipramine; Conditioning, Operan

2012
Neonatal tricyclic antidepressant clomipramine treatment reduces the spike-wave discharge activity of the adult WAG/Rij rat.
    Brain research bulletin, 2012, Nov-01, Volume: 89, Issue:3-4

    Topics: Action Potentials; Age Factors; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Choice

2012
Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression.
    Journal of proteome research, 2012, Dec-07, Volume: 11, Issue:12

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Behavior, Animal; Body

2012
Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish.
    Journal of applied toxicology : JAT, 2014, Volume: 34, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cardiotoxins; Clomipramine; Cyclophosphamide; Disease

2014
Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 104

    Topics: Animals; Behavior, Animal; Clomipramine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Flu

2013
Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.
    The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:6

    Topics: Action Potentials; Animals; Animals, Newborn; Clomipramine; Compulsive Behavior; Conditioning, Opera

2013
The chronic psychosocial stress paradigm in male tree shrews: evaluation of a novel animal model for depressive disorders.
    Stress (Amsterdam, Netherlands), 2002, Volume: 5, Issue:1

    Topics: Animals; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Disease Models, Animal

2002
Sleep-wake effects of yohimbine and atropine in rats with a clomipramine-based model of depression.
    Neuroreport, 2002, Sep-16, Volume: 13, Issue:13

    Topics: Acetylcholine; Adrenergic alpha-Agonists; Aggression; Animals; Animals, Newborn; Antidepressive Agen

2002
Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume.
    Molecular psychiatry, 2002, Volume: 7, Issue:9

    Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Brain Chemistry; Cell Division; Chronic Dise

2002
Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression.
    Neuroscience, 2002, Volume: 115, Issue:4

    Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depressive Disorder; Dise

2002
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
    Neuron, 2003, Jun-05, Volume: 38, Issue:5

    Topics: Animals; Arousal; Carrier Proteins; Cells, Cultured; Clomipramine; Disease Models, Animal; Efferent

2003
Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat.
    Pharmacological research, 2003, Volume: 48, Issue:2

    Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Carrageenan; Clomipramine; Dise

2003
Corticosterone and testosterone levels after chronic stress in an animal model of depression.
    Neuropsychobiology, 2003, Volume: 48, Issue:2

    Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal;

2003
Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine.
    Brain research, 2003, Nov-21, Volume: 991, Issue:1-2

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Blotting, Western; Brain; Clomipramine;

2003
[Effect of concurrent treatment of SSRI on the tyrosine hydroxylase immunoreactivity in the rat locus coeruleus treated with chronic variable stress].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2004, Volume: 24, Issue:1

    Topics: Animals; Antidepressive Agents, Tricyclic; Chronic Disease; Clomipramine; Corticotropin-Releasing Ho

2004
Antidepressants blunt the effects of inescapable stress on male mating behaviour and decrease corticotropin-releasing hormone mRNA expression in the hypothalamic paraventricular nucleus of the Syrian hamster (Mesocricetus auratus).
    Journal of neuroendocrinology, 2004, Volume: 16, Issue:7

    Topics: Animals; Antidepressive Agents, Tricyclic; Avoidance Learning; Clomipramine; Corticotropin-Releasing

2004
Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews.
    Behavioural pharmacology, 2004, Volume: 15, Issue:5-6

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cell Differentiation; Clomipramine

2004
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).
    European journal of pharmacology, 2005, Sep-27, Volume: 520, Issue:1-3

    Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Corticosterone; Depressio

2005
Antidepressant treatment reduces Fos-like immunoreactivity induced by swim stress in different columns of the periaqueductal gray matter.
    Brain research bulletin, 2006, Oct-16, Volume: 70, Issue:4-6

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Cell Count; Clomipramine; Desipramine; Disease

2006
Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents.
    Neuroscience letters, 2007, Jun-21, Volume: 421, Issue:1

    Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Dep

2007
Sucrose preference is restored by electro-acupuncture combined with chlorimipramine in the depression-model rats.
    Acupuncture & electro-therapeutics research, 2006, Volume: 31, Issue:3-4

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Combined Modality Therapy; Depressio

2006
Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3

    Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagon

2007
Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus.
    Behavioural brain research, 2008, Mar-17, Volume: 188, Issue:1

    Topics: Animals; Antidepressive Agents; Chronic Disease; Clomipramine; Depressive Disorder; Disease Models,

2008
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:6

    Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Behavior, An

2008
Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression.
    Neuroreport, 1995, Mar-07, Volume: 6, Issue:4

    Topics: Animals; Antidepressive Agents; Citalopram; Clomipramine; Disease Models, Animal; Male; Membrane Pot

1995
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
    Psychopharmacology, 1993, Volume: 112, Issue:2-3

    Topics: Animals; Clomipramine; Conditioning, Operant; Desipramine; Diazepam; Disease Models, Animal; Drinkin

1993
The effects of a 3-day increase of ambient temperature on body temperature and REM sleep in an animal model of depression.
    Sleep, 1994, Volume: 17, Issue:4

    Topics: Acclimatization; Animals; Animals, Newborn; Body Temperature Regulation; Circadian Rhythm; Clomipram

1994
Decreased raphe unit activity in a rat model of endogenous depression.
    Brain research, 1993, May-14, Volume: 611, Issue:1

    Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Electric Stimulation; Evoked Pot

1993
Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine.
    Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:5

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clomipramine; Depression; Disea

1995
Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle.
    Archives of medical research, 1996,Spring, Volume: 27, Issue:1

    Topics: Animals; Antidepressive Agents, Tricyclic; Clomipramine; Disease Models, Animal; Estrus; Female; Mot

1996
Fluoride and pilocarpine reduce the risk of caries produced by chronic clomipramine treatment in rats.
    Caries research, 1997, Volume: 31, Issue:2

    Topics: Administration, Oral; Analysis of Variance; Animals; Cariostatic Agents; Cholinergic Antagonists; Cl

1997
Pharmacological features of masculine sexual behavior in an animal model of depression.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Clo

1998
Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).
    Behavioral neuroscience, 1998, Volume: 112, Issue:6

    Topics: Animals; Clomipramine; Disease Models, Animal; Dopamine Agonists; Male; Obsessive-Compulsive Disorde

1998
Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression.
    Journal of neural transmission (Vienna, Austria : 1996), 1998, Volume: 105, Issue:10-12

    Topics: Animals; Animals, Newborn; Clomipramine; Depression; Depression, Chemical; Dexamethasone; Disease Mo

1998
Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression.
    Neurochemical research, 1999, Volume: 24, Issue:3

    Topics: Aggression; Animals; Biogenic Monoamines; Brain; Brain Stem; Clomipramine; Depression; Disease Model

1999
Effects of neonatal clomipramine treatment on locomotor activity, anxiety-related behavior and serotonin turnover in Syrian hamsters.
    Neuropsychobiology, 1999, Volume: 39, Issue:4

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Brain Chemis

1999
Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
    Neuroscience letters, 2000, May-26, Volume: 286, Issue:1

    Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomi

2000
Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:6

    Topics: Animals; Antidepressive Agents; Benzamides; Clomipramine; Depression; Disease Models, Animal; Dose-R

2000
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments?
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001, Volume: 11, Issue:3

    Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depression; Disease Model

2001
Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats.
    Pharmacology, 2001, Volume: 63, Issue:3

    Topics: Amoxapine; Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Depression; Disease Model

2001
Altered dendritic spine density in animal models of depression and in response to antidepressant treatment.
    Synapse (New York, N.Y.), 2001, Dec-01, Volume: 42, Issue:3

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Dendrites; Denervation; D

2001
Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors.
    Sleep, 2002, Mar-15, Volume: 25, Issue:2

    Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depress

2002
Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression.
    Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:4

    Topics: Animals; Animals, Newborn; Clomipramine; Defecation; Depressive Disorder; Disease Models, Animal; Ma

1992
Compulsive feather picking in birds.
    Archives of general psychiatry, 1991, Volume: 48, Issue:9

    Topics: Animals; Animals, Domestic; Bird Diseases; Clomipramine; Disease Models, Animal; Female; Humans; Mal

1991
Procedure- and age-dependent hyperactivity in a new animal model of endogenous depression.
    Neuroscience and biobehavioral reviews, 1990,Spring, Volume: 14, Issue:1

    Topics: Aging; Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Disease Models, Animal; Hy

1990
Diminished sexual activity in a new animal model of endogenous depression.
    Neuroscience and biobehavioral reviews, 1990,Spring, Volume: 14, Issue:1

    Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Rats; Rats, Inbred Strains; Sexu

1990
REM sleep abnormalities in a new animal model of endogenous depression.
    Neuroscience and biobehavioral reviews, 1990,Spring, Volume: 14, Issue:1

    Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Male; Rats; Rats, Inbred Strains

1990
Treatment of behavioral disorders in animals.
    The American journal of psychiatry, 1990, Volume: 147, Issue:9

    Topics: Animal Diseases; Animals; Animals, Domestic; Clomipramine; Desipramine; Disease Models, Animal; Dog

1990
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:1

    Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Bicuculline; Chlorophenols; Cl

1987
Animal depression model by neonatal clomipramine: reduction of shock induced aggression.
    Pharmacology, biochemistry, and behavior, 1988, Volume: 31, Issue:1

    Topics: Age Factors; Aggression; Animals; Animals, Newborn; Clomipramine; Depression; Disease Models, Animal

1988